AIM: We critically evaluated empiric antibiotic practice in the surgical and trauma intensive care unit (STICU) with three specific objectives: (1) To characterize empiric antibiotics practice prospectively; (2) to determine how frequently STICU patients started on empiric antibiotics subsequently have a confirmed infection; and (3) to elucidate the complications associated with unnecessary empiric antibiotic therapy. METHODS: We collected data prospectively using the Surgical Intensive Care-Infection Registry (SIC-IR) including all 1,185 patients admitted to the STICU for >2 days from March 2007 through May 2008. Empiric antibiotics were defined as those initiated because of suspected infections. RESULTS: The mean patient age was 56 years and 62% were male. The mean STICU length of stay was eight days, and the mortality rate was 4.6%. Empiric antibiotics were started for 26.3% of the patients. The average length of antibiotic use was three days. Of the 312 patients started on empiric antibiotics, only 25.6% were found to have an infection. Factors associated with correctly starting empiric antibiotics were a longer STICU stay (5 vs. 3 days), prior antibiotics (29% vs. 17%), and mechanical ventilation (93% vs. 79%). Patients who were started on antibiotics without a subsequent confirmed infection were compared with patients not given empiric antibiotics. Incorrect use of empiric antibiotics was associated with younger age (p < 0.001), more STICU days (10.6 vs. 5.9 days; p < 0.001), more ventilator days (p < 0.001), more development of acute renal failure (24.1% vs. 12.1%; p < 0.001), and a significant difference in mortality rate (8.6% vs. 3.2%; p < 0.001). CONCLUSIONS: After admission to the STICU, 26% of patients received at least one course of empiric antibiotics. Only 25.6% of these patients were confirmed to have an infection. These results provide key benchmark data for the critical care community to improve antibiotic stewardship.
AIM: We critically evaluated empiric antibiotic practice in the surgical and trauma intensive care unit (STICU) with three specific objectives: (1) To characterize empiric antibiotics practice prospectively; (2) to determine how frequently STICU patients started on empiric antibiotics subsequently have a confirmed infection; and (3) to elucidate the complications associated with unnecessary empiric antibiotic therapy. METHODS: We collected data prospectively using the Surgical Intensive Care-Infection Registry (SIC-IR) including all 1,185 patients admitted to the STICU for >2 days from March 2007 through May 2008. Empiric antibiotics were defined as those initiated because of suspected infections. RESULTS: The mean patient age was 56 years and 62% were male. The mean STICU length of stay was eight days, and the mortality rate was 4.6%. Empiric antibiotics were started for 26.3% of the patients. The average length of antibiotic use was three days. Of the 312 patients started on empiric antibiotics, only 25.6% were found to have an infection. Factors associated with correctly starting empiric antibiotics were a longer STICU stay (5 vs. 3 days), prior antibiotics (29% vs. 17%), and mechanical ventilation (93% vs. 79%). Patients who were started on antibiotics without a subsequent confirmed infection were compared with patients not given empiric antibiotics. Incorrect use of empiric antibiotics was associated with younger age (p < 0.001), more STICU days (10.6 vs. 5.9 days; p < 0.001), more ventilator days (p < 0.001), more development of acute renal failure (24.1% vs. 12.1%; p < 0.001), and a significant difference in mortality rate (8.6% vs. 3.2%; p < 0.001). CONCLUSIONS: After admission to the STICU, 26% of patients received at least one course of empiric antibiotics. Only 25.6% of these patients were confirmed to have an infection. These results provide key benchmark data for the critical care community to improve antibiotic stewardship.
Authors: Marc Leone; Frédéric Garcin; Julien Bouvenot; Ioanna Boyadjev; Pierre Visintini; Jacques Albanèse; Claude Martin Journal: Crit Care Med Date: 2007-02 Impact factor: 7.598
Authors: Joseph F Golob; Adam M A Fadlalla; Justin A Kan; Nilam P Patel; Charles J Yowler; Jeffrey A Claridge Journal: J Am Coll Surg Date: 2008-06-24 Impact factor: 6.113
Authors: Mary-Anne W Aarts; Christian Brun-Buisson; Deborah J Cook; Anand Kumar; Steven Opal; Graeme Rocker; Terry Smith; Jean-Louis Vincent; John C Marshall Journal: Intensive Care Med Date: 2007-06-09 Impact factor: 17.440
Authors: Galo Peralta; M Blanca Sánchez; J Carlos Garrido; Inés De Benito; M Eliecer Cano; Luis Martínez-Martínez; M Pía Roiz Journal: J Antimicrob Chemother Date: 2007-07-20 Impact factor: 5.790
Authors: Jeffrey A Claridge; Joseph F Golob; Adam M A Fadlalla; Beth M D'Amico; Joel R Peerless; Charles J Yowler; Mark A Malangoni Journal: Surg Infect (Larchmt) Date: 2009-02 Impact factor: 2.150
Authors: José Garnacho-Montero; Carlos Ortiz-Leyba; Inmaculada Herrera-Melero; Teresa Aldabó-Pallás; Aurelio Cayuela-Dominguez; Juan A Marquez-Vacaro; Jesus Carbajal-Guerrero; Jose L Garcia-Garmendia Journal: J Antimicrob Chemother Date: 2007-12-03 Impact factor: 5.790
Authors: Elan L Guterman; Hooman Kamel; Carmil Azran; Maulik P Shah; J Claude Hemphill; Wade S Smith; Babak B Navi Journal: Neurocrit Care Date: 2014-08 Impact factor: 3.210